Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

SNBP

Sun BioPharma (SNBP)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNBP
DataOraFonteTitoloSimboloCompagnia
21/06/202323:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNBPSun BioPharma Inc
04/05/202322:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNBPSun BioPharma Inc
28/04/202322:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNBPSun BioPharma Inc
18/04/202322:16Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SNBPSun BioPharma Inc
29/03/202322:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNBPSun BioPharma Inc
20/03/202311:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNBPSun BioPharma Inc
20/03/202311:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SNBPSun BioPharma Inc
16/03/202321:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNBPSun BioPharma Inc
14/02/202320:45Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNBPSun BioPharma Inc
10/02/202323:20Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SNBPSun BioPharma Inc
30/01/202322:39Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNBPSun BioPharma Inc
26/01/202314:07Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-1mef)NASDAQ:SNBPSun BioPharma Inc
26/01/202312:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNBPSun BioPharma Inc
23/01/202312:04Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:SNBPSun BioPharma Inc
04/11/202211:00Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNBPSun BioPharma Inc
03/10/202223:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SNBPSun BioPharma Inc
20/07/202212:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNBPSun BioPharma Inc
27/06/202214:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNBPSun BioPharma Inc
23/06/202212:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SNBPSun BioPharma Inc
16/06/202214:16Edgar (US Regulatory)Notification That a Class of Securities of Successor Issuer Is Demed to Be Registered Pursuant to Section 12(b) (8-k12b)NASDAQ:SNBPSun BioPharma Inc
30/06/202112:07Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:SNBPSun BioPharma Inc
04/05/202122:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SNBPSun BioPharma Inc
26/03/202113:41Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SNBPSun BioPharma Inc
08/12/202014:00GlobeNewswire Inc.Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Lin...NASDAQ:SNBPSun BioPharma Inc
01/12/202017:30GlobeNewswire Inc.Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.NASDAQ:SNBPSun BioPharma Inc
12/11/202022:10GlobeNewswire Inc.Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial ResultsNASDAQ:SNBPSun BioPharma Inc
10/11/202014:00GlobeNewswire Inc.Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select ConferenceNASDAQ:SNBPSun BioPharma Inc
02/11/202014:00GlobeNewswire Inc.Sun BioPharma, Inc. Schedules Conference Call on November 12, 2020 to Report 2020 Third Quarter Financial ResultsNASDAQ:SNBPSun BioPharma Inc
01/09/202023:42Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SNBPSun BioPharma Inc
01/09/202022:10GlobeNewswire Inc.Sun BioPharma, Inc. Closes $10.5 Million Public Offering of Common Stock and WarrantsNASDAQ:SNBPSun BioPharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNBP
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network